Evaluation of Biological Activity of New 1,2,4-Triazole Derivatives Containing Propionic Acid Moiety

Molecules. 2023 Apr 29;28(9):3808. doi: 10.3390/molecules28093808.

Abstract

To this day, the quest to find new drugs is still a challenge due to the growing demands of patients suffering from chronic inflammatory diseases and the need for the individualization of therapy. The aim of this research was to synthesize new 1,2,4-triazole derivatives containing propanoic acid moiety and to investigate their anti-inflammatory, antibacterial and anthelmintic activity. Compounds 3a-3g were obtained in reactions of amidrazones 1a-1g with succinic anhydride. Several analyses of proton and carbon nuclear magnetic resonance (1H NMR, 13C NMR, respectively), as well as high-resolution mass spectra (HRMS), confirmed the structures of 1,2,4-triazole derivatives 3a-3g. Toxicity, antiproliferative activity and influence on cytokine release (TNF-α: Tumor Necrosis Factor-α, IL-6: Interleukin-6, IFN-γ: Interferon-γ, and IL-10: Interleukin-10) of the compounds 3a-3g were evaluated in peripheral blood mononuclear cells culture. Moreover, mitogen-stimulated cell culture was used for biological activity tests. The antimicrobial and anthelmintic activity of derivatives 3a-3g were studied against Gram-positive and Gram-negative bacterial strains and Rhabditis sp. culture. Despite the lack of toxicity, compounds 3a-3g significantly reduced the level of TNF-α. Derivatives 3a, 3c and 3e also decreased the release of IFN-γ. Taking all of the results into consideration, compounds 3a, 3c and 3e show the most beneficial anti-inflammatory effects.

Keywords: 1,2,4-triazole derivatives; Rhabditis sp.; TNF-α; amidrazones; anti-inflammatory; cytokines; propanoic acid.

MeSH terms

  • Anti-Infective Agents*
  • Anti-Inflammatory Agents / pharmacology
  • Humans
  • Interleukin-6
  • Leukocytes, Mononuclear
  • Propionates* / pharmacology
  • Tumor Necrosis Factor-alpha

Substances

  • 1,2,4-triazole
  • propionic acid
  • Propionates
  • Tumor Necrosis Factor-alpha
  • Anti-Inflammatory Agents
  • Anti-Infective Agents
  • Interleukin-6

Grants and funding

This work has been supported by Nicolaus Copernicus University, (IDUB DEBIUTY4) and funds for the statutory activity of the Medical University of Lublin DS43 (A.B.-K.).